StockData
Revelation Biosciences, Inc. logo

Revelation Biosciences, Inc. (REVB) income statement

REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.50−0.19 (-5.15%)

Close on Nov 20, 2026Market cap $13.94MP/E –Yield –

Revelation Biosciences, Inc. financial ratios

See a number that looks wrong?